Radiomics
PrivateLast Round
Grant
Apr 7, 2023
Total Funding Raised
$9.27M
Company Overview
Radiomics is a biotechnology company providing an AI-powered medical imaging and advanced statistics platform to optimize the development of new oncology treatments for biotech and pharma companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Radiomics Comps
Public and private peers based on sector, stage, and business model.
Radiomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 7, 2023 | ||||
| Series A | Nov 17, 2021 | ||||
| Seed | Feb 20, 2018 |
Radiomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public service of Wallonia | Grant |
| Noshaq | Seed, Series A |
| Epimede | Series A |
| LeanSquare | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 36% MoM, reaching 1.2K.
- May 3, 2025
Monthly visitors grew 148% MoM.
Radiomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Radiomics's valuation, stock price, and market status.
